Treatment strategies for patients with HER2-positive gastric cancer

Cancer Biol Med. 2024 Feb 5;20(12):934-941. doi: 10.20892/j.issn.2095-3941.2023.0480.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents, Immunological* / therapeutic use
  • Humans
  • Receptor, ErbB-2
  • Stomach Neoplasms* / drug therapy

Substances

  • Receptor, ErbB-2
  • Antineoplastic Agents, Immunological